PFE
Pfizer Inc.
- Net income, 2025
- $7.8B
- YoY, 2025
- −3.2%
- 5-year CAGR
- −3.2%
- 10-year CAGR
- +1.1%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $7.8B | −3.2% |
| 2024 | $8.0B | +279.0% |
| 2023 | $2.1B | −93.2% |
| 2022 | $31.4B | +42.7% |
| 2021 | $22.0B | +140.0% |
| 2020 | $9.2B | −42.8% |
| 2019 | $16.0B | +43.7% |
| 2018 | $11.2B | −47.7% |
| 2017 | $21.3B | +195.3% |
| 2016 | $7.2B | +3.7% |
| 2015 | $7.0B | −23.8% |
| 2014 | $9.1B | −58.5% |
| 2013 | $22.0B | +51.0% |
| 2012 | $14.6B | +45.6% |
| 2011 | $10.0B | +21.2% |
| 2010 | $8.3B | −4.4% |
| 2009 | $8.6B | +6.6% |
| 2008 | $8.1B | −0.5% |
| 2007 | $8.1B | — |